Green Thumb Industries (GTBIF) Gains from Investment Securities (2019 - 2026)
Green Thumb Industries (GTBIF) reported Gains from Investment Securities of $155000.0 for Q1 2026, up 100.7% quarter-over-quarter from -$22.1 million in Q4 2025.
Green Thumb Industries (GTBIF) Gains from Investment Securities (2019 - 2026) Analysis & Trends
Green Thumb Industries has reported Gains from Investment Securities for 8 years, with the latest figure at $155000.0 in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities changed N/A year-over-year to $155000.0; the trailing twelve-month figure through Mar 2026 stood at -$111.4 million (down 34.88% YoY), and the FY2025 full-year result was $7.7 million, down 6.62% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at $155000.0, up from -$22.1 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $8.5 million in Q3 2024, with the low at -$89.5 million in Q4 2024.
- Historically, Gains from Investment Securities has averaged -$5.0 million across 5 years, with a median of $1.0 million in 2022.
- Annual changes were most pronounced in 2022 — Gains from Investment Securities soared 1038.92% — and 2024, when it sank 3083.99%.
- Green Thumb Industries' Gains from Investment Securities stood at $3.9 million in 2022, then slipped by 23.18% to $3.0 million in 2023, then slumped by 3083.99% to -$89.5 million in 2024, then soared by 75.35% to -$22.1 million in 2025, then soared by 100.7% to $155000.0 in 2026.
- The last three Gains from Investment Securities figures came in at $155000.0 (Q1 2026), -$22.1 million (Q4 2025), and $5.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Green Thumb Industries | - | - | 143.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 155,000.00 |
| Mar 31, 2026 | 155,000.00 |
| Dec 31, 2025 | -22.06 Mn |
| Dec 31, 2025 | -22.06 Mn |
| Sep 30, 2025 | 5.58 Mn |
| Sep 30, 2025 | 5.58 Mn |
| Jun 30, 2025 | 5.48 Mn |
| Jun 30, 2025 | 5.48 Mn |
| Dec 31, 2024 | -89.49 Mn |
| Dec 31, 2024 | -89.49 Mn |
| Sep 30, 2024 | 8.49 Mn |
| Sep 30, 2024 | 8.49 Mn |
| Jun 30, 2024 | 797,289.00 |
| Jun 30, 2024 | 797,289.00 |
| Dec 31, 2023 | 3.00 Mn |
| Dec 31, 2023 | 3.00 Mn |
| Sep 30, 2023 | 3.31 Mn |
| Sep 30, 2023 | 3.31 Mn |
| Jun 30, 2023 | 3.09 Mn |
| Jun 30, 2023 | 3.09 Mn |